// App-Quantinova.ai

PO0657 : Artificial Intelligence-Driven Target Identification in CKD

Researchers

Presenter

  • Kumar Chanchal

Principal Investigators

  • Buvall Lisa

  • Ryaboshapkina Maria

  • Woollard Kevin

  • Williams Julie

  • Kurbatova Natalie

  • Reznichenko Anna

  • MacPhee Iain

  • Bohlooly Mohammad

  • Paul DirkS

  • Dunbar James

  • Taddei Andrea

  • Davies Mark

  • McMahon Siobhan

  • Mori Andres

  • Fritsche-Danielson Regina

  • Bendtsen Claus

  • Laerkegaard Hansen PernilleB

Medical Centers

  • Renal Bioscience Research and Early Development Cardiovascular Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • Renal Bioscience Research and Early Development Cardiovascular Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • Renal Bioscience Research and Early Development Cardiovascular Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • Quantitative Biology Research and Early Development Discovery Sciences BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • Renal Bioscience Research and Early Development Cardiovascular Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • Translational Genomics Research and Early Development Discovery Biology BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden

  • Quantitative Biology Research and Early Development Discovery Sciences BioPharmaceuticals R&D AstraZeneca Cambridge United Kingdom

  • BenevolentAI London United Kingdom

Locations

  • Sweden

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A